Stocks

As pot stocks race to the bottom, more companies are turning to debt financing for quick cash

Revenues grew 281 per cent for the Calgary-based company, but it also recorded a $3.7 million loss in the last quarter.

Four cannabis companies placed in the top eight hottest growing stocks on the inaugural Toronto Stock Exchange's top 30 list.

Nearly all pot stocks have declined double digits since March as investors become wary of promises over results and in September the sector kept taking a beating.

The California-based company is expanding its retail footprint in Florida, the third largest medical marijuana market in the U.S. with 260,000 patients.

In a note titled, “Don’t Smoke the Kool-Aid,” MKM Partners analyst Bill Kirk warned investors the pot industry may see little profits, but he was bullish on Hexo because of its brand power.

The Toronto-based pot firm plans to accelerate production of its high-THC strain Unite Organic as strong demand has prompted an early second order from the OCS.

The Calgary-based company launched two new stores last week in the Wild Rose province and has its sights on operating 25 pot shops in total nationwide by mid-September.

The company's Las Vegas pot store is not only the world's largest attracting more than 115,000 visitors in August, but it accounts for almost 10% of the Nevada cannabis market alone.

The company behind a blockchain-based seed to sale tracking technology is bolstering its status by adding heavyweight auditing firm Deloitte and pot producer Aphria.

Employees at the embattled pot producer allegedly sourced out black market cannabis seeds and tainted the legal supply with illicit weed, according to BNN Bloomberg.

Aurora Cannabis nets $86.5 million in cash by selling its remaining stake in The Green Organic Dutchman as both companies strategies evolve.

Vivien Azer at Cowen & Co. cut her price target on the Canadian pot producer to $60 from $150, but she believes the stock's recent collapse presents a buying opportunity.

The Denver-based company recorded a 35% jump in revenue from last quarter as it saw increased demand for its distinct cannabis brand in California and Michigan.

The Ottawa-based pot firm saw its revenues surge from its California operations, and it expects further growth once its acquisition by Chicago-based Cresco Labs is approved and closes.

Despite Curaleaf reporting wider losses and lower-than-expected revenues in the second-quarter, investors remained upbeat on its more than US$1-billion revenue guidance for 2020.

The Vancouver-based pot producer inked a deal with a "Canadian beverage technology company" to ready itself for the coming next-phase infused product launch in Canada later this year.

The Toronto-based pot company is the latest to make its foray into the U.S. by acquiring Quill, a multi-state vape technology brand known for its health-focused disposable vape pens.

Analysts have been bullish on the U.K. drugmaker raising estimates and price targets after its second-quarter sales easily surpassed expectations.

The California-based pot retailer will provide a same-day home delivery service and offer more than 400 products across the state, which is considered the largest legal cannabis market.

Shares of Canopy sunk to their lowest level this year, as the Ontario-based cannabis giant saw pot sales decline in Canada for the third straight quarter while losses continue to pile.

Acreage shares fell 10 per cent after it posted a second-quarter loss of US$33.9 million, but the American pot firm said it plans to open up pot shops under Canopy's brands across the U.S.

Shares of the B.C.-based pot producer tumbled after it posted a wider-than-expected loss for the second quarter and despite revenues nearly doubling from the last quarter.

While investors brace for cannabis companies to post quarterly losses, the Barrie, Ont.-based pot extractor reported a second-quarter profit ahead of the launch of Cannabis 2.0 products.

In previous years greenhouse operator Village Farms mainly grew tomatoes, but now the Vancouver-based company cannabis joint venture is helping it turn bigger quarterly profits.

As the cannabis industry reaches the heart of earnings season, investors are looking for profits and weren't impressed with Cronos CEO's second-half spending projections in its Q2 report.

Problems continue to mount for CannTrust after it revealed Health Canada found several new regulatory breaches at the cannabis company's Vaughan, Ont. manufacturing facility.

Shares in CannTrust swung wildly on Friday after the embattled pot producer revealed its outside auditor was withdrawing its year-end and first-quarter reports.

The Columbus-based CBD retailer will have 105 of its Seventh Sense shops open in malls across the U.S. by Aug. 8.

America's No. 1 selling iced tea brand is going to pot by inking a licensing deal with Colorado-based Dixie Brands to make and sell cannabis-infused gummies, drinks and vape pens.

The Phoenix-based company owns, operates or manages six cultivation and production facilities and 11 retail stores across eight states and began trading on the Canadian Securities Exchange on Aug. 6.

While embattled cannabis producer CannTrust awaits its fate with Health Canada for its regulatory breach, Aphria told Bloomberg it might consider buying the troubled company's assets.

The troubled Canadian pot company hired Greenhill & Co Inc. to help it conduct a "review of strategic alternatives," including finding a buyer, while it awaits federal enforcement action.

But Canada's largest pot retailer posted a net loss of $4.8 million in its third quarter as expenses continue to mount for the company that now has 34 stores open.

The latest distribution deal with Kroger gives the Colorado-based company a total of five tie-ups with major U.S. retailers to ship its hemp CBD topical products into a total of 8,000 U.S. locations.

The Moncton, N.B.-based company reported third-quarter losses and an eight per cent drop in sales as Ontario cannabis reorders also waned in the quarter that ended May 31.

Negative headlines and an industry-wide struggle to record profits have been hurting investor confidence in cannabis stocks in 2019.

The "BWell Market" will offer hemp-derived CBD products to U.S. customers and try to cash in on the CBD buzz.

The Ontario Cannabis Store said it won't be selling CannTrust's pot products until Health Canada conducts its investigation on how the company grew weed illegally.